Hiroyasu Sakai Selected Research

Hiroyasu Sakai Research Topics

Disease

29	Asthma (Bronchial Asthma) 01/2021 - 02/2004
26	Inflammation (Inflammations) 12/2021 - 12/2005
24	Carcinogenesis 12/2021 - 09/2008
23	Neoplasms (Cancer) 01/2022 - 10/2009
19	Respiratory Hypersensitivity 10/2019 - 12/2003
13	Obesity 03/2020 - 09/2008
12	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 04/2008
8	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 09/2008
7	Muscular Atrophy (Muscle Atrophy) 01/2022 - 07/2014
7	Body Weight (Weight, Body) 02/2017 - 09/2008
6	Liver Neoplasms (Liver Cancer) 09/2020 - 04/2008
5	Atrophy 01/2022 - 01/2019
5	Colonic Neoplasms (Colon Cancer) 12/2020 - 07/2010
5	Allergic Rhinitis 01/2011 - 05/2006
4	Alcoholic Fatty Liver 09/2018 - 12/2015
4	Fatty Liver 09/2017 - 01/2011
4	Non-alcoholic Fatty Liver Disease 08/2017 - 04/2014
3	Weight Loss (Weight Reduction) 01/2022 - 03/2016
3	Contact Dermatitis (Eczema, Contact) 12/2019 - 08/2017
3	Diarrhea 01/2017 - 01/2013
3	Diabetes Mellitus 03/2016 - 09/2008
3	Insulin Resistance 01/2016 - 02/2010
3	Hyperalgesia 03/2015 - 06/2012
3	Neuralgia (Stump Neuralgia) 04/2014 - 06/2012
3	Liver Cirrhosis (Hepatic Cirrhosis) 12/2012 - 12/2009
3	Aberrant Crypt Foci 05/2012 - 09/2008
3	Nasal Obstruction 10/2010 - 07/2006
2	Adenoma (Adenomas) 01/2022 - 03/2016
2	Colitis 12/2021 - 01/2021
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021 - 09/2018
2	Ichthyosis (Xeroderma) 01/2021 - 08/2019
2	Infections 09/2020 - 09/2019
2	Dermatitis 01/2018 - 08/2017
2	Liver Diseases (Liver Disease) 09/2017 - 08/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2017 - 01/2016
2	Hyperinsulinism (Hyperinsulinemia) 03/2016 - 01/2016
2	Fibrosis (Cirrhosis) 08/2015 - 12/2009

Drug/Important Bio-Agent (IBA)

21	AntigensIBA 10/2019 - 01/2005
17	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2004
9	Messenger RNA (mRNA)IBA 01/2018 - 02/2004
8	Pharmaceutical PreparationsIBA 01/2022 - 01/2011
8	CytokinesIBA 10/2020 - 02/2004
7	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 07/2014
7	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2022 - 02/2010
7	Insulin-Like PeptidesIBA 12/2021 - 04/2008
7	TeaIBA 04/2017 - 10/2009
6	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 01/2013
6	3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA 01/2016 - 11/2009
5	Interleukin-6 (Interleukin 6)IBA 06/2020 - 03/2010
5	Drinking WaterIBA 03/2020 - 09/2008
5	Phosphotransferases (Kinase)IBA 11/2017 - 10/2009
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 02/2004
5	AdipokinesIBA 03/2016 - 07/2010
5	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2016 - 10/2009
4	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2022 - 01/2011
4	AzoxymethaneIBA 12/2021 - 09/2008
4	rhoA GTP-Binding ProteinIBA 01/2021 - 12/2003
4	Interleukin-13IBA 10/2020 - 02/2009
4	rho-Associated KinasesIBA 06/2017 - 12/2008
4	tyrosine receptor (receptor, tyrosine)IBA 03/2015 - 10/2009
3	UbiquitinIBA 01/2022 - 01/2020
3	CateninsIBA 01/2022 - 06/2011
3	Aquaporins (Water Channels)IBA 01/2021 - 01/2013
3	LigandsIBA 01/2021 - 10/2012
3	Insulin (Novolin)FDA Link 03/2020 - 04/2008
3	ChemokinesIBA 12/2019 - 03/2010
3	LipidsIBA 01/2019 - 06/2011
3	RetinoidsIBA 09/2017 - 11/2009
3	Interleukin-17 (Interleukin 17)IBA 06/2017 - 01/2013
3	Branched-Chain Amino AcidsIBA 01/2016 - 02/2010
3	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 10/2010 - 01/2010
3	GlucocorticoidsIBA 01/2010 - 04/2008
2	Ubiquitinated ProteinsIBA 01/2022 - 01/2020
2	Dextrans (Dextran)FDA Link 12/2021 - 03/2010
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 12/2021 - 03/2010
2	MicroRNAs (MicroRNA)IBA 10/2020 - 01/2017
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2020 - 01/2018
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2020 - 05/2006
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020 - 01/2019
2	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 12/2019 - 08/2017
2	Streptozocin (Streptozotocin)FDA Link 08/2019 - 09/2017
2	InflammasomesIBA 01/2019 - 01/2018
2	Prostaglandin D2IBA 01/2019 - 01/2018
2	HaptensIBA 01/2018 - 08/2017
2	PlatinumIBA 11/2017 - 07/2014
2	CurcuminIBA 08/2017 - 01/2012
2	CarcinogensIBA 02/2017 - 03/2010
2	AntioxidantsIBA 03/2016 - 03/2015
2	Sodium Glutamate (Accent)IBA 03/2016 - 12/2015
2	AdiponectinIBA 03/2016 - 06/2011
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2015 - 07/2006
2	salicylhydroxamic acid (SHAM)IBA 04/2014 - 05/2013
2	Serotonin (5 Hydroxytryptamine)IBA 12/2013 - 06/2012

Therapy/Procedure

17	Chemoprevention 12/2021 - 04/2008
11	Therapeutics 09/2020 - 02/2007
7	Drug Therapy (Chemotherapy) 01/2022 - 12/2013
4	Subcutaneous Injections 09/2017 - 07/2010
2	Diet Therapy (Therapy, Diet) 12/2021 - 07/2014
2	Intranasal Administration 01/2018 - 08/2010
2	Ligation 03/2015 - 06/2012